Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | lactate dehydrogenase LDH2 | 0.0053 | 1 | 0.5 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0053 | 1 | 1 |
Echinococcus multilocularis | L lactate dehydrogenase B chain | 0.0053 | 1 | 1 |
Schistosoma mansoni | malate dehydrogenase | 0.0053 | 1 | 0.5 |
Toxoplasma gondii | malate dehydrogenase MDH | 0.0053 | 1 | 0.5 |
Plasmodium vivax | lactate dehydrogenase | 0.0053 | 1 | 0.5 |
Plasmodium falciparum | L-lactate dehydrogenase | 0.0053 | 1 | 0.5 |
Echinococcus multilocularis | lactate dehydrogenase protein | 0.0053 | 1 | 1 |
Toxoplasma gondii | lactate dehydrogenase LDH1 | 0.0053 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | malate dehydrogenase | 0.0053 | 1 | 0.5 |
Echinococcus granulosus | L lactate dehydrogenase B chain | 0.0053 | 1 | 1 |
Echinococcus granulosus | lactate dehydrogenase a | 0.0053 | 1 | 1 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0053 | 1 | 1 |
Entamoeba histolytica | malate dehydrogenase, putative | 0.0053 | 1 | 0.5 |
Echinococcus granulosus | lactate dehydrogenase protein | 0.0053 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 1 | 0.5 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0053 | 1 | 1 |
Echinococcus granulosus | lactate dehydrogenase a | 0.0053 | 1 | 1 |
Schistosoma mansoni | L-lactate dehydrogenase | 0.0053 | 1 | 0.5 |
Plasmodium falciparum | malate dehydrogenase | 0.0053 | 1 | 0.5 |
Leishmania major | malate dehydrogenase, putative | 0.0053 | 1 | 0.5 |
Plasmodium vivax | malate dehydrogenase, putative | 0.0053 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 5 uM | Inhibitory concentration value against murine P-388 tumor cell line | ChEMBL. | 15658869 |
IC50 (functional) | > 5 uM | Inhibitory concentration value against human A-549 tumor cell line | ChEMBL. | 15658869 |
IC50 (functional) | > 5 uM | Inhibitory concentration value against human colon adenocarcinoma HT-29 tumor cell line | ChEMBL. | 15658869 |
IC50 (functional) | > 5 uM | Inhibitory concentration value against human MEL-28 or human cancer HeLa tumor cell line | ChEMBL. | 15658869 |
IC50 (functional) | > 5 uM | Inhibitory concentration value against human colon carcinoma H-116 or human cancer HL-60 tumor cell line | ChEMBL. | 15658869 |
IC50 (functional) | > 5 uM | Inhibitory concentration value against murine P-388 tumor cell line | ChEMBL. | 15658869 |
IC50 (functional) | > 5 uM | Inhibitory concentration value against human A-549 tumor cell line | ChEMBL. | 15658869 |
IC50 (functional) | > 5 uM | Inhibitory concentration value against human colon adenocarcinoma HT-29 tumor cell line | ChEMBL. | 15658869 |
IC50 (functional) | > 5 uM | Inhibitory concentration value against human colon carcinoma H-116 or human cancer HL-60 tumor cell line | ChEMBL. | 15658869 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 15658869 | |
Mus musculus | ChEMBL23 | 15658869 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.